US Stock MarketDetailed Quotes
KTTA Pasithea Therapeutics
- 3.0500
- -0.0500-1.61%
Close Nov 25 16:00 ET
- 3.0000
- -0.0500-1.64%
Post 19:01 ET
3.86MMarket Cap-205P/E (TTM)
3.1901High3.0000Low22.04KVolume3.1900Open3.1000Pre Close68.23KTurnover2.15%Turnover RatioLossP/E (Static)1.27MShares17.400052wk High0.22P/B3.13MFloat Cap2.920052wk Low--Dividend TTM1.02MShs Float170.0000Historical High--Div YieldTTM6.13%Amplitude2.9200Historical Low3.0950Avg Price1Lot Size
Pasithea Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 3.63%-3.12M | -31.15%-4.04M | -34.94%-4.32M | -7.73%-12.81M | -3.42%-3.29M | 29.94%-3.24M | -59.12%-3.08M | -48.79%-3.2M | -274.74%-11.89M | -82.61%-3.19M |
| Net income from continuing operations | 16.96%-3M | -7.45%-3.87M | -18.22%-3.86M | -32.23%-15.51M | -24.12%-5.03M | 13.80%-3.61M | -64.31%-3.6M | -152.46%-3.27M | -439.58%-11.73M | -743.25%-4.05M |
| Operating gains losses | 256.25%70.31K | 119.96%35.62K | -157.00%-26.72K | 93.45%-121.29K | 105.64%55.31K | -113.42%-45K | 57.68%-178.47K | 105.97%46.87K | 20.66%-1.85M | 62.09%-980.51K |
| Depreciation and amortization | 0.00%162.26K | -0.00%162.26K | 0.33%162.26K | 12,629.76%648.45K | 3,820.28%162.22K | 16,225,700.00%162.26K | 16,854.75%162.26K | --161.72K | 269.40%5.09K | 200.07%4.14K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | --960 | --960 | 96,100.00%960 | ---- | ---- |
| Change In working capital | -485.87%-501.06K | -268.69%-531.45K | -191.69%-942.26K | 86.22%1.57M | -13.97%1.45M | 117.32%129.85K | 171.95%315.04K | -54.63%-323.04K | 659.97%845.35K | 3,028.64%1.69M |
| -Change in receivables | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---15.78K | ---- | ---- |
| -Change in prepaid assets | 247.20%250.97K | 2,107.89%468.16K | -200.84%-822.51K | 291.03%346.48K | 57.54%769.17K | 67.94%-170.49K | -78.95%21.2K | -14.65%-273.4K | 44.95%-181.37K | 262.27%488.25K |
| -Change in payables and accrued expense | -1,572.63%-758.35K | -322.39%-1.04M | -249.64%-118.37K | 43.61%1.07M | 143.76%682.9K | -111.18%-45.34K | 1,437.84%467.26K | -214.56%-33.86K | 69.23%745.76K | 446.66%280.15K |
| -Change in other current assets | -98.17%6.32K | 121.40%40.5K | --58 | 160.19%158.29K | -99.50%1.8K | 160.15%345.68K | ---189.2K | --0 | ---262.99K | --358.29K |
| -Change in other current liabilities | --0 | ---963 | ---1.45K | -100.28%-1.55K | -100.28%-1.55K | --0 | --0 | --0 | --543.96K | --561.52K |
| Cash from discontinued investing activities | 0 | 0 | 0 | -11.25K | -3,836.11%-399.69K | 55.39%-183.44K | ||||
| Operating cash flow | 3.96%-3.12M | -16.08%-4.04M | -27.63%-4.32M | -7.73%-12.81M | 15.24%-2.7M | 23.03%-3.25M | -80.77%-3.48M | -32.08%-3.39M | -274.74%-11.89M | -82.61%-3.19M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 103.27%75.2K | 102.33%54.54K | 293.16%50.16K | -65.21%24.39K | -2,662.07%-53.89K | -10,594.78%-2.3M | -18,007.96%-2.34M |
| Net PPE purchase and sale | --0 | --0 | --0 | 67.97%-34.3K | 100.04%36 | 513.03%22.66K | 55.21%-3.11K | -2,662.07%-53.89K | -398.07%-107.1K | -616.96%-92.73K |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---2.19M | ---2.25M |
| Net other investing changes | ---- | ---- | ---- | --109.5K | --54.5K | --27.5K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 113.63%399.01K | 102.40%54.54K | 126.98%50.16K | 194.99%344.01K | 54.19%-49.7K | -13,510.18%-2.93M | -17,452.08%-2.27M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 217.65%4.54M | 0 | 0 | -16.22%-3.73M | 0 | -3.86M | -130.77K | 264.1K | -105.73%-3.21M | -109.38%-3.21M |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | ---133.34K | ---130.77K | --264.1K | --0 | --0 |
| Net common stock issuance | ---- | ---- | ---- | -16.22%-3.73M | --0 | ---- | ---- | ---- | -106.38%-3.21M | -111.80%-3.21M |
| Cash from discontinued financing activities | 65.98%-611.28K | -1.8M | -769.68K | |||||||
| Financing cash flow | 217.65%4.54M | --0 | --0 | 13.30%-4.34M | 84.63%-611.28K | -275.86%-3.86M | ---130.77K | --264.1K | -108.94%-5M | -111.64%-3.98M |
| Net cash flow | ||||||||||
| Beginning cash position | -70.10%7.97M | -59.85%12.01M | -50.64%16.33M | -37.45%33.09M | -53.79%19.58M | -44.36%26.65M | -40.44%29.91M | -37.45%33.09M | 21,612.28%52.9M | 106.07%42.38M |
| Current changes in cash | 120.13%1.42M | -23.66%-4.04M | -36.26%-4.32M | 15.49%-16.75M | 65.47%-3.26M | -29.90%-7.06M | -42.82%-3.27M | -18.69%-3.17M | -137.59%-19.82M | -129.10%-9.43M |
| Effect of exchange rate changes | -537.52%-27.13K | -818.61%-2.91K | 75.03%-620 | -140.31%-3.99K | -97.80%3.07K | 94.84%-4.26K | 99.25%-317 | 44.98%-2.48K | 193.74%9.9K | 2,150.61%139.42K |
| End cash Position | -52.20%9.36M | -70.10%7.97M | -59.85%12.01M | -50.64%16.33M | -50.64%16.33M | -53.79%19.58M | -44.36%26.65M | -40.44%29.91M | -37.53%33.09M | -37.53%33.09M |
| Free cash flow | 3.28%-3.12M | -15.98%-4.04M | -25.63%-4.32M | -7.06%-12.85M | 17.64%-2.7M | 23.66%-3.23M | -80.28%-3.48M | -34.08%-3.44M | -275.57%-12M | -86.55%-3.28M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data